Whole Exome Sequencing Guides Pharmacotherapy for an Adolescent With Autism Spectrum Disorder and Psychosis.
Journal
Journal of the American Academy of Child and Adolescent Psychiatry
ISSN: 1527-5418
Titre abrégé: J Am Acad Child Adolesc Psychiatry
Pays: United States
ID NLM: 8704565
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
08
06
2018
revised:
24
09
2018
accepted:
19
10
2018
entrez:
6
3
2019
pubmed:
6
3
2019
medline:
3
6
2020
Statut:
ppublish
Résumé
Genomic testing, including whole exome sequencing (WES), can result in specific changes to medical management. To illustrate the clinical utility of WES for complex neuropsychiatric disease, we report a male adolescent with autism spectrum disorder, psychosis, and regression and discuss how the WES findings guided his pharmacologic management.
Identifiants
pubmed: 30832905
pii: S0890-8567(18)31895-1
doi: 10.1016/j.jaac.2018.09.432
pii:
doi:
Substances chimiques
DNA-Binding Proteins
0
Transcription Factors
0
HIVEP2 protein, human
148770-78-9
Types de publication
Case Reports
Letter
Langues
eng
Sous-ensembles de citation
IM
Pagination
376-377Informations de copyright
Copyright © 2018 American Academy of Child and Adolescent Psychiatry. All rights reserved.